LLY compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ARCTArcturus Therapeutics Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only ARCT 3

—Biomedical Advanced Research and Development Authority (BARDA)unlistedcustomer

—CSL Seqirusunlistedcustomer

—Meiji Seika Pharmaunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ARCTArcturus Therapeutics Holdings Inc.

9.37▼−13.76%· post 9.37

ClosedNov 5 '26

Mkt cap$309.0MRevenue$18MQ3 FY26Revenue$82MFY25

Compare

ClosedNov 5 '26

LLYELI Lilly & Co

ARCTArcturus Therapeutics Holdings Inc.

1,371.32▼−3.29%post 1,363.77

Price

9.37▼−13.76%post 9.37

$1.2T

Mkt cap

$309.0M

Q3 FY26$24.4B

Revenue

$18MQ3 FY26

FY25$65.2B

Revenue

$82MFY25

LLY1,371.32▼−3.29%vsARCT9.37▼−13.76%ClosedNov 5 '26